Publication

The State of Research Funding for Interventional Chronic Pain Therapies

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Sunil Agarwal, Emory UniversityChristopher Gharibo, NYU Grossman School of MedicineMichael E Schatman, NYU Grossman School of Medicine
Language
  • English
Date
  • 2023-05-31
Publisher
  • Dove Medical Press
Publication Version
Copyright Statement
  • © 2023 Agarwal et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 16
Start Page
  • 1825
End Page
  • 1828
Abstract
  • Chronic pain is among the most common chronic conditions in the United States, with over 50.2 million adults (20.5%) reporting pain either daily or on most days.1 Only recently has pain medicine research, generally, begun to receive increased federal funding and increased attention compared to other areas of medical research. Unfortunately, the majority of funding for pain medicine research remains focused on opioid use, misuse, and addiction,2 despite data demonstrating that the “prescription opioid crisis” of the early years of the current millennium ended a number of years ago.3,4 In the United States, there continues to be a lack of access to federal funding agencies dedicated to research in interventional pain medicine, which has significant implications for the development of effective treatments for chronic pain. This analysis will address the state of pain medicine research, the funding concerns associated with pain medicine research, and potential solutions to improve the quality of pain medicine research in the United States.
Author Notes
  • Michael E Schatman, Department of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, 550 1st Ave, New York, NY, 10016, USA, Tel +1 425-647-4880, Email Michael.Schatman@NYULangone.org
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items